Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/65531
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGonzález Castillo, Celia-
dc.contributor.authorOrtuño Sahagún, Daniel-
dc.contributor.authorGuzmán-Brambila, Carolina-
dc.contributor.authorPallàs i Llibería, Mercè, 1964--
dc.contributor.authorRojas-Mayorquín, Argelia E.-
dc.date.accessioned2015-05-13T16:17:10Z-
dc.date.available2015-05-13T16:17:10Z-
dc.date.issued2015-01-08-
dc.identifier.issn1662-5102-
dc.identifier.urihttps://hdl.handle.net/2445/65531-
dc.description.abstractPleiotrophin (PTN) is a secreted growth factor, and also a cytokine, associated with the extracellular matrix, which has recently starting to attract attention as a significant neuromodulator with multiple neuronal functions during development. PTN is expressed in several tissues, where its signals are generally related with cell proliferation, growth, and differentiation by acting through different receptors. In Central Nervous System (CNS), PTN exerts post-developmental neurotrophic and -protective effects, and additionally has been involved in neurodegenerative diseases and neural disorders. Studies in Drosophila shed light on some aspects of the different levels of regulatory control of PTN invertebrate homologs. Specifically in hippocampus, recent evidence from PTN Knock-out (KO) mice involves PTN functioning in learning and memory. In this paper, we summarize, discuss, and contrast the most recent advances and results that lead to proposing a PTN as a neuromodulatory molecule in the CNS, particularly in hippocampus.-
dc.format.extent7 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3389/fncel.2014.00443-
dc.relation.ispartofFrontiers in Cellular Neuroscience, 2015, vol. 8, p. 443-
dc.relation.urihttp://dx.doi.org/10.3389/fncel.2014.00443-
dc.rightscc-by (c) González-Castillo, Celia et al., 2015-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationSistema nerviós central-
dc.subject.classificationHipocamp (Cervell)-
dc.subject.classificationNeuropèptids-
dc.subject.classificationCitoquines-
dc.subject.classificationNeurobiologia-
dc.subject.otherCentral nervous system-
dc.subject.otherHippocampus (Brain)-
dc.subject.otherNeuropeptides-
dc.subject.otherCytokines-
dc.subject.otherNeurobiology-
dc.titlePleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec646138-
dc.date.updated2015-05-13T16:17:10Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid25620911-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Files in This Item:
File Description SizeFormat 
646138.pdf638.78 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons